AD

Alirocumab(CAS: 1245916-14-6)

Alirocumab
CAS Number

Related Products

Other Suppliers for Alirocumab

Basic Information

Molecular Formula
C3H9Na2O6P
Molecular Weight
218.05 g/mol

Chemical Identifiers

SMILES
C(C(COP(=O)(O)O)O)O.[Na].[Na]
InChIKey
CATWCRUATKKAAQ-UHFFFAOYSA-N

FAQ

Alirocumab (CAS: 1245916-14-6) is a monoclonal antibody used to lower cholesterol levels in patients with high cholesterol, particularly those with familial hypercholesterolemia or those unable to tolerate statins.
Alirocumab (CAS: 1245916-14-6) is primarily used for the treatment of heterozygous familial hypercholesterolemia and as an adjunct to maximally tolerated statin therapy in adults to reduce low-density lipoprotein cholesterol (LDL-C).
Alirocumab (CAS: 1245916-14-6) is generally considered safe. However, it may cause side effects such as injection site reactions, headache, and nausea. Patients should inform their healthcare provider if they experience any unusual symptoms.
Alirocumab (CAS: 1245916-14-6) should be stored at 2°C to 8°C (36°F to 46°F) in the refrigerator. It should be kept away from light and not frozen. The medication should be protected from excessive heat and humidity. Do not shake the vial before use.

Safety Notice

Please verify product specifications and safety data before use. Contact the supplier for detailed safety information.

Always follow proper handling procedures

Contact Information

Email

sz@meryer.com

Mobile

18025840623

Fax

021-61259101